GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

Rakovina Therapeutics RKV.V · CAD

N/A · TSX Venture · 🇨🇦 Canada

Compare

0.18

-10.00%

Close of 9 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Rakovina Therapeutics — daily TSXV:RKV Delayed
Market value
C$3.8m
Last close × shares
Volume
9.3k
Shares, 9 Nov 2026

About Rakovina Therapeutics

Its shares trade on TSX Venture under the ticker RKV.V. It has been listed since 7 February 2020.

Rakovina Therapeutics, Inc. focuses on the development of new cancer treatments based on novel DNA-damage response technologies. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2020-02-07. The firm is engaged in advancing cancer therapies based on deoxyribonucleic acid (DNA)-damage response technologies. The firm has a pipeline of DNA-damage response inhibitors to advance one or more drug candidates into human clinical trials and obtain marketing approval for cancer therapeutics. The Company’s research programs include kt-2000, kt-3000 and kt-4000. The kt-2000 next generation PARP-inhibitors. The kt-3000 class drug candidates are rationally designed to overcome treatment resistance by selectively downregulating DNA double-strand (DSB) repair mechanisms while enhancing PARP inhibitor activity. The kt-4000 series lead candidates release a potent methylation agent causing damage to a tumor cell’s DNA while also inhibiting DNA-damage repair mechanisms to cancer cell death.

Figures and description from our data supplier, not checked against the company's own report.

More about Rakovina Therapeutics →

Latest on Rakovina Therapeutics

Our reporting

We have not reported on Rakovina Therapeutics yet.

Next results

26 Nov 2026

Due on 26 Nov 2026.

Other N/A listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Rakovina Therapeutics's ticker?

Rakovina Therapeutics trades as RKV.V on TSX Venture, under ISIN CA75103L3092.

What was Rakovina Therapeutics's last closing price?

0.18 on 9 Nov 2026. The figure is in CAD and is never converted.

When does Rakovina Therapeutics next report results?

Results are expected on 26 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.